Estudo muito esperado sobre prevenção da doença de Alzheimer não encontra nenhum benefício clínico de medicamento direcionado a amiloide; aponta para a necessidade de considerar outras abordagens.

Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches – JAMA (gratuito por tempo limitado)

Comentário no Twitter

The hypothesis that amyloid deposits in the brain cause Alzheimer disease has gotten many hits over the years, as one antiamyloid treatment after another failed to show a clinical benefit. Time to move on? @RitaRubin writes about the debate. https://t.co/913A0WWcR7

— JAMA (@JAMA_current) August 17, 2022